Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 208-217

  Anichini, Andrea ^a   Mortarini, Roberta ^a   Maccalli, Cristina ^a   Squarcina, Paola ^a   Fleischhauer, Katharina ^b   Mascheroni, Luigi ^a   Parmiani, Giorgio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Gene Therapy Program   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN; HLA A2 ANTIGEN; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HLA TYPING; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROLYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CLONE CELLS; HLA-A2 ANTIGEN; HUMANS; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0030029651     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Van der Bruggen, P , C Traversari, P. Chomez, C. Lurquin, E. De Plaen. B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254 1643
2. Brichard, V , A. Van Pel, T Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med. 178. 489.
3. Coulie, P., V Brichard, A Van Pel, T. Wölfel, J. Schneider, C Traversan, E De Plaen, C. Lurquin, J. P. Szikora, J. C. Renauld, and T. Boon. 1994. A new gene encoding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp Med. 180:35.
4. Kawakami, Y., S Eliyahu, C. H. Delgado, P F Robbins, L Rivoltini, S L. Topalian, T Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl. Acad Sci USA 91:3515.
5. Bakker, A B. H., M. W. J. Schreurs, A. J. de Boer, Y. Kawakami, S. A Rosenberg, G. J. Adema, and C. G. Figdor 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes J. Exp. Med 179:1005
6. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F Robbins, K. Sakaguchi. E. Appella, J. R. Yannelli, G. J. Adema, T. Miki, and S A. Rosenberg 1994 Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl. Acad Sci USA 91 6458.
7. Wang, R. F., P F. Rohhins, Y. Kawakami, X. Q. Kang, and S. A. Rosenberg 1995. Identification of a gene encoding a melanoma rumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181:799
8. Gaugler, B., B. van den Eynde, P van der Bruggen, P Romero, J. J. Gaforio, E De Plaen, B. Lethe, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921.
9. Boel, P., C Wildmann, M. L. Sensi, R Brasseur, J C. Renauld, P. Coulie, T. Boon, and P. Van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes Immunity 2:167.
10. Robbins, P. F., M. El-Gamil, Y. F Li, S L. Topalian, L. Rivoltini, K. Sakaguchi, E. Appella, Y. Kawakami, and S. A Rosenberg. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J. Immunol. 154:5944.
11. Slingluff, C. L , A. L Cox, R A. Henderson, D. F. Hunt, and V. H. Engelhard. 1993. Recognition of human melanoma cells by HLA-A2.1 restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J. Immunol 150:2955.
12. Mazzocchi, A , F Belli, L Mascheroni, C Vegetti, G. Parmiani, and A. Anichini. 1994 Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients. Int. J. Cancer 58:330.
13. Lee, T. D. 1990. Distributions of HLA antigens. In The HLA System. J. Lee, ed Springer Verlag, New York, p. 141.
14. Crowley, N. J., T. L. Darrow, M. A Quinn-Allen, and H. F. Seigler. 1991. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells: evidence for restriction by a dominant HLA-A allele. J. Immunol. 146. 1692
15. Kawakami, Y , S Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J R. Yanelli, E. Appella, and S. A Rosenberg. 1994. Identification of the immuno-dominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med. 180: 347
16. Van der Bruggen, P., J Bastin, T. Gajewski, P G Coulie, P. Boel, C. De Smet, C. Traversari, A. Townsend, and T. Boon. 1994. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J. Immunol. 24:3038.
17. Wolfel, T., A. Van Pel, V. Brichard, J. Schneider, B Seliger, K. H. M. zum Buschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J Immunol. 24:759
18. Cox, A. L , J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow, V. H. Engelhard, D. F. Hunt, and C L Slingluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716.
19. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette, E. Appella, and S A Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol 154:3961.
20. + cytotoxic T lymphocytes. J. Exp. Med. 181.363.
21. Anichini, A., C Maccalli, R. Mortarini, S Salvi, A. Mazzocchi, P. Squarcina, M Herlyn, and G Parmiani. 1993. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med. 177:989.
22. Herlyn, M., U. Rodeck, M. L Mancianti, F. M. Cardillo, A Lang, A. H Ross, J. Jambrosic, and H Koprowski. 1987. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture Cancer Res. 47.3057.
23. Houghton, A N., A. P. Albino, C. Cordon Cardo, L. J. Davis, and M. Eisinger. 1988. Cell surface antigens of human melanocytes and melanoma: expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J. Exp. Med. 167:197
24. Lassam, N , and S. Bickford. 1992 Loss of c-kit expression in cultured melanoma cells. Oncogene 7:51.
25. Taswell, C , H R MacDonald, and J. C. Cerottini. 1980. Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens. J. Exp. Med 151:1372.
26. Russo, C., A. K Ng, M. A. Pellegrino, and S. Ferrone. 1983. The monoclonal antibody CR11 351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18.23.
27. Bodmer, J. G., S. G. E. Marsh, E D Albert, W. F. Bodmer, B. Dupont, H. A Erlich, B. Mach, W R. Mayr, P Parham, T. Sasazuki, G M T. Schreuder, J. L. Strominger, A Svejgaard, and P. I, Terasaki 1994. Nomenclature for factors of the HLA system. Tissue Antigens 44:1.
28. Marsh, S. G E. 1995 Nomenclature for factors of the HLA system, update January 1995. Tissue. Antigens 45.220.
29. Tiercy, J. M., N. Djavad, N. Rufer, D. E. Speiser, M Jeannet, and E. Roosnek 1994. Oligotyping of HLA-A2, -A3 and -B44 subtypes detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors Hum. Immunol. 41:207.
30. Parham, P., C. J. Barnstable, and W. F. Bodmer. 1979. Use of monoclonal antibody (W6/32) in structural studies of HLA-A, -B, -C antigens. J. Immunol 121.342.
31. Lefkovits, I , and H Waldmann 1984. Limiting dilution analysis of immune system. 1. The clonal basis of the immune response. Immunol. Today 5:265
32. RAS peptide presented by HLA-A2 1. Int J Cancer 61:389.
33. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281.
34. Bernhard, H., J. Karbach, T. Wolfel, P. Busch, S Storkel, M. Stockle, C. Wölfel, B. Seliger, C. Huber, K. H. Meyer-zum-Buschenfelde, and A. Knuth. 1994 Cellular immune response to human renal-cancer cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int J Cancer 59:837
35. Natali, P. G , M R. Nicotra, A. Bigotti, I. Venturo, L. Marcenaro, P Giacomini, and C Russo. 1989. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc Natl. Acad. Sci. USA 86:6719.
36. Restifo, N. P , F. Esquival, Y. Kawakami, J. W Yewdell, J J. Mule', S. A. Rosenberg, and J R. Bennick. 1993. Identification of human cancers deficient in antigen processing J Exp. Med. 17.265
37. Parmiani, G. 1993 Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells. Immunol. Today 14:536.
38. Celis, E., J. Fikes, P. Wentworth, J. Sidney, S. Southwood, A Maewal, M. F. Del Guercio, A. Sette, and B Livingston. 1994. Identification of potential CTL. epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles. Mol Immunol 31.1423.